Ampa
Overview
Ampa is a neurotechnology company that makes Ampa One, a portable, lightweight, camera-guided, FDA-cleared TMS device. Ampa One is available via subscription with no upfront cost or per-treatment fee. Ampa One is pioneering One-Day TMS treatment and is designed to make an established therapy practical for practices that previously could not offer it. Founded by researchers who helped pioneer modern TMS protocols, Ampa's mission is to enable one billion remissions from mental and neurological disorders.
More in Neurotechnology
Latest industry news
Google and HHMI Janelia Publish the Complete Fruit Fly Brain Connectome — Built With AI
2026-09-28 · Research
St. Jude Wins FDA Approval for Neurostimulation Device Patients Can Upgrade Without Surgery
2026-09-28 · Policy
Flourish Emerges From Stealth With Bezos and Google Ventures Backing to Target Neuroscience
2026-09-27 · Funding
At-Home Neuromodulation Devices Are Moving Depression Treatment Out of the Clinic
2026-09-26 · Product
Company details
Category
🏢 Neurotechnology
Funding
Private
Listed
2026-07-10
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →